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Behavioural genetic studies contrast with molecular genetic
studies of Attention Deficit hyperactivity disorder (ADHD). Doyle
et al., in their comprehensive review, make clear that
heritability estimates from twin studies clearly indicate that
there is a strong genetic component in ADHD with heritabilty
ranging from 0.6 to 0.9.1 In contrast, molecular genetic studies
of ADHD have identified non-overlapping chromosomal regions
that may contain possible susceptibility genes. This difference
between behavioural ratings and molecular findings clearly
poses currently a problem for advocates of an endophenotype
approach to ADHD.
The term “endophenotype” refers to a phenotype thought to
be closer to the biological factors causing a clinical disorder,
in contrast to a clinical phenotype, which refers to the clinical
signs and symptoms of a syndrome.2
The assumption of the endophenotype approach is that it
will be possible to identify more easily the neuro-biological
factors that underlie the disorder rather than identifying the
genetic factors associated with the clinical syndrome. The
argument is that the reduced complexity is due to firstly the
endophenotype’s proximity to the genes thought to produce
the disorder and, secondly,  to the potent ia l  that the
endophenotype can better specify the factors that lead to the
cl inical  syndrome. This argument assumes that the
endophenotype is better able to discriminate the condition from
other conditions and non-cases than the phenotype itself. A
further assumption is that the endophenotype truly reflects
the pathological processes causing the condition and not
epiphenomena associated with the syndrome but which have
no causal relation to the clinical condition.
It seems worthwhile at this stage in the field’s development to
evaluate briefly the success of the endophenotypic approach in
better differentiating the ADHD condition from non-cases and
associated disorders. The proponents of the approach have used
primarily neuropsychological models to define the ADHD
endophenotype. A f irst study employed well-defined
neuropsychological tasks, acquired DNA material and contrasted
the rigorously defined ADHD sample with well-defined controls.3
The phenotypic distinction between the groups differentiated
the ADHD from the control group and did so in terms of
neuropsychological functioning. Disappointingly, no relationship
was found between the endophenotypes: inhibition, response
control with the DRD4-7 repeat allele.
Since then an international hunt for a valid endophenotype
has commenced to determine the re lat ion between
neuropsychological processes and genes. A problem here is
that the neuropsychological tasks have identified only 35%-
50% of combined-type ADHD subjects as exhibiting deficits
on processes thought key to the disorder: inhibi t ion,
interference control, and processing speed/set shifting.
Combining across measures the neuropsychological measures
does not substantially increase the number of individuals with
impairments.4 Hence, a critical weakness of the endophenotype
approach is that it employs neuropsychological measures,which
do not have the sensitivity nor the specificity to identify to a
high degree the clinical phenotype. Differentiation between
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ADHD and disorders such as High Function Autism and
Tourette’s disorder on neuropsychological measures has proven
to be difficult.5 Similarly, other neuropsychological measures
such as working memory on the basis of a recent meta-analysis
show only modest differentiation between the ADHD phenotype
and controls. It has been argued that the variability in speed
of processing might be the best candidate for endophenotype
research. Unfor tunately, this measure has found to be
associated with High Function Autism to an even greater
degree than with ADHD.5
In view of this, it is evident that the endophenotype approach
has not revealed a short-cut to identifying the causal factors
of ADHD. The measures current ly used to def ine the
endophenotype are too weak in their sensitivity, lack sufficient
specificity and have, currently, no known predictive power for
the developmental course of the disorder. This raises the
pragmatic quest ion of whether the investment in the
endophenotype is worth it at this point in time? Would the
field not be better to take stock and identify the neuropsycho-
biological processes that differentiate ADHD from controls,
accounts for its subtypes and associated disorders as well as
from syndromes with putative neuropsychological deficits
proposed to account for ADHD? Without this first step being
achieved one may wonder what is the gain in endophenotypes,
when the phenotype relationship to neuro-biological proces-
ses is unclear.
Joseph Sergeant
Clinical Neuropsychology, Vrije Universiteit, Amsterdam
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